DAXOR Corporation is a publicly traded company registered on NYSE MKT (DXR). We are an innovative medical instrumentation and biotechnology company. We manufacture the BVA-100 Blood Volume Analyzer, the first instrument approved by the FDA to provide rapid direct measurement of a patient’s blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.
Our IDANT division provides (1) semen banking services, which include anonymous donor semen and semen storage, (2) autologous blood storage, (3) andrology services, which include semen analysis and sperm washing, and (4) general lab testing.
Ultimately the company’s mission is to help hospitals and physicians incorporate DAXOR’s advanced technologies to significantly improve the quality of patient care.